Bristol-Myers Squibb, Ventiv ink multi-year service deal

Share this article:
Bristol-Myers Squibb and Ventiv Pharma Services have signed a multi-year service agreement under which Ventiv will provide a sales force of more than 375 representatives focusing on Cefzil and Tequin.
Under the terms of the agreement, Ventiv Pharma also will provide BMS with the entire field and internal management staff, full operational support to include sales force automation, help desk support and analysis and reporting services, according to a Ventiv statement. Ventiv Pharma is a division of Ventiv Health Inc.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?